Video Report: A Drug for Ovarian Cancer?
Author and Disclosure Information

Two trials show bevacizumab delays the progression of ovarian cancer. In this interview, Dr. Andrew Seidman puts the trials into perspective.

Two trials show bevacizumab delays the progression of ovarian cancer. In this interview, Dr. Andrew Seidman puts the trials into perspective.